Keyan Yang

413 total citations
27 papers, 272 citations indexed

About

Keyan Yang is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Keyan Yang has authored 27 papers receiving a total of 272 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Public Health, Environmental and Occupational Health and 5 papers in Molecular Biology. Recurrent topics in Keyan Yang's work include CAR-T cell therapy research (5 papers), Acute Lymphoblastic Leukemia research (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Keyan Yang is often cited by papers focused on CAR-T cell therapy research (5 papers), Acute Lymphoblastic Leukemia research (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Keyan Yang collaborates with scholars based in China, India and United States. Keyan Yang's co-authors include Tie-Shan Tang, Caixia Guo, Chaoqiang An, Xi Wang, Ying Hu, Yihan Wang, Henghui Zhang, Yun Wang, Fei Gao and Qiaochu Wang and has published in prestigious journals such as Blood, Applied Physics Letters and Biochemical and Biophysical Research Communications.

In The Last Decade

Keyan Yang

25 papers receiving 271 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keyan Yang China 9 93 89 34 31 29 27 272
Jiaqi Wang China 10 132 1.4× 52 0.6× 78 2.3× 47 1.5× 15 0.5× 48 366
Emanuela Stampone Italy 12 168 1.8× 103 1.2× 56 1.6× 15 0.5× 14 0.5× 22 325
Qianqian Shan China 9 103 1.1× 64 0.7× 47 1.4× 53 1.7× 15 0.5× 19 313
Ştefana Oana Purcaru Romania 12 148 1.6× 73 0.8× 90 2.6× 30 1.0× 27 0.9× 24 342
Patrycja Sujka‐Kordowska Poland 11 192 2.1× 81 0.9× 53 1.6× 31 1.0× 64 2.2× 27 335
Thatchawan Thanasupawat Canada 14 211 2.3× 67 0.8× 80 2.4× 34 1.1× 82 2.8× 27 404
Habibe Demir United States 6 174 1.9× 70 0.8× 51 1.5× 22 0.7× 46 1.6× 9 321
G. Ian Gallicano United States 9 229 2.5× 125 1.4× 48 1.4× 42 1.4× 35 1.2× 10 432
Milena Guidi Italy 7 104 1.1× 70 0.8× 53 1.6× 39 1.3× 20 0.7× 23 280
Rahel Fitzel Germany 4 141 1.5× 68 0.8× 66 1.9× 29 0.9× 10 0.3× 7 302

Countries citing papers authored by Keyan Yang

Since Specialization
Citations

This map shows the geographic impact of Keyan Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keyan Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keyan Yang more than expected).

Fields of papers citing papers by Keyan Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keyan Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keyan Yang. The network helps show where Keyan Yang may publish in the future.

Co-authorship network of co-authors of Keyan Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Keyan Yang. A scholar is included among the top collaborators of Keyan Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keyan Yang. Keyan Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Wei, Ying Liu, Keyan Yang, et al.. (2025). Clinical features, mutational landscape and their prognostic impact in Chinese paediatric patients with T‐cell lymphoblastic lymphoma. British Journal of Haematology. 207(5). 1994–2005.
2.
3.
Wu, Xiaoxue, Zhiqiang Qi, Xinyi Li, et al.. (2024). Polymerizable deep eutectic solvent treated lignocellulose: Green strategy for synergetic production of tough strain sensing elastomers and nanocellulose. International Journal of Biological Macromolecules. 264(Pt 2). 130670–130670. 7 indexed citations
4.
Liu, Hongmei, Tingting Li, Song Zhao, et al.. (2024). Agomirs upregulating carboxypeptidase E expression rescue hippocampal neurogenesis and memory deficits in Alzheimer’s disease. Translational Neurodegeneration. 13(1). 24–24. 8 indexed citations
5.
Li, Zhihui, Qinlong Zheng, Keyan Yang, et al.. (2024). CD7 CART Therapy Bridging Allo-HSCT Remarkably Improves Long-Term DFS in Refractory/Relapsed T-ALL/LBL. Transplantation and Cellular Therapy. 31(2). 73.e1–73.e11. 1 indexed citations
6.
Yang, Li, Yang Liu, Keyan Yang, et al.. (2023). Impact of ARID1A and TP53 mutations in pediatric refractory or relapsed mature B-Cell lymphoma treated with CAR-T cell therapy. Cancer Cell International. 23(1). 281–281. 2 indexed citations
7.
Liu, Hongmei, Tingting Li, Song Zhao, et al.. (2023). Restoring carboxypeptidase E rescues BDNF maturation and neurogenesis in aged brains. PubMed. 2(2). lnad015–lnad015. 5 indexed citations
8.
Zhao, Song, Keyan Yang, Yuxin Zhang, et al.. (2023). ER Ca2+ overload activates the IRE1α signaling and promotes cell survival. Cell & Bioscience. 13(1). 123–123. 18 indexed citations
9.
Han, Xiangsheng, et al.. (2023). Chitosan/WS2 nanosheets co-assembled aerogels with anisotropic micro-channels for efficient Pb(II) adsorption. Desalination and Water Treatment. 282. 163–176. 3 indexed citations
10.
Li, Zhihui, Keyan Yang, Yanzhi Song, et al.. (2023). CAR-T therapy followed by allogeneic hematopoietic stem cell transplantation for refractory/relapsed acute B lymphocytic leukemia: Long-term follow-up results. Frontiers in Oncology. 12. 1048296–1048296. 7 indexed citations
11.
Yang, Keyan, Lihua Yu, Lulu Huang, et al.. (2023). Poor outcome of pediatric B-cell acute lymphoblastic leukemia associated with high level of CRLF2 gene expression in distinct molecular subtypes. Frontiers in Oncology. 13. 1256054–1256054. 1 indexed citations
12.
13.
Yang, Keyan, Song Zhao, Jiaqi Shen, et al.. (2022). Ca2+ homeostasis maintained by TMCO1 underlies corpus callosum development via ERK signaling. Cell Death and Disease. 13(8). 674–674. 6 indexed citations
14.
Li, Zhihui, Na An, Keyan Yang, et al.. (2022). Donor CD7 Chimeric Antigen Receptor T Cell Bridging to Allogeneic Hematopoietic Stem Cell Transplantation for T Cell Hematologic Malignancy. Transplantation and Cellular Therapy. 29(3). 167–173. 19 indexed citations
15.
Lü, Zhihao, Huan Chen, Xi Jiao, et al.. (2021). Germline HLA-B evolutionary divergence influences the efficacy of immune checkpoint blockade therapy in gastrointestinal cancer. Genome Medicine. 13(1). 175–175. 12 indexed citations
16.
Zhao, Chuanhua, Lihong Wu, Dandan Liang, et al.. (2021). Identification of immune checkpoint and cytokine signatures associated with the response to immune checkpoint blockade in gastrointestinal cancers. Cancer Immunology Immunotherapy. 70(9). 2669–2679. 6 indexed citations
17.
Chen, Huan, Keyan Yang, Guanxiong Zhang, et al.. (2020). Peripheral cytokine levels as predictive biomarkers of benefit from immune checkpoint inhibitors in cancer therapy. Biomedicine & Pharmacotherapy. 129. 110457–110457. 25 indexed citations
18.
Yang, Keyan, Shu‐Ming Li, Xiaoqing Liu, & Aili Fan. (2020). Reinvestigation of the substrate specificity of a reverse prenyltransferase NotF from Aspergillus sp. MF297-2. Archives of Microbiology. 202(6). 1419–1424. 3 indexed citations
19.
Wang, Xi, Tingting Li, Keyan Yang, et al.. (2019). ER stress mediated degradation of diacylglycerol acyltransferase impairs mitochondrial functions in TMCO1 deficient cells. Biochemical and Biophysical Research Communications. 512(4). 914–920. 17 indexed citations
20.
Zhu, Shu, Yihan Wang, Fengli Wang, et al.. (2019). Miro2 supplies a platform for Parkin translocation to damaged mitochondria. Science Bulletin. 64(11). 730–747. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiaqi Wang Breakdown of academic impact, for papers by Emanuela Stampone Breakdown of academic impact, for papers by Qianqian Shan Breakdown of academic impact, for papers by Ştefana Oana Purcaru Breakdown of academic impact, for papers by Patrycja Sujka‐Kordowska Breakdown of academic impact, for papers by Thatchawan Thanasupawat Breakdown of academic impact, for papers by Habibe Demir Breakdown of academic impact, for papers by G. Ian Gallicano Breakdown of academic impact, for papers by Milena Guidi Breakdown of academic impact, for papers by Rahel Fitzel
Rankless by CCL
2026